Journals / Bakırköy Tıp Dergisi / 2018 / Cilt: 14 - Sayı: 2

Sclerotherapy and complications in telangiectasia veins

Telenjiektazik Venlerde Skleroterapi ve Komplikasyonları

Pages
222–241
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is primarily a cosmetic procedure, so it is quite important to know about its possible complications and how to handle them

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Lower extremity varicose veins are a widespread illness which cause serious losses in the quality of life and workforce.
📊
Key Findings & Data:They are generally 0.1 to 1 mm.
💡
Conclusion & Impact:It is primarily a cosmetic procedure, so it is quite important to know about its possible complications and how to handle them
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Lower extremity varicose veins are a widespread illness which cause serious losses in the quality of life and workforce. Telangiectasia capillaries are purple-colored enlarged structures formed in venous part of the circulation. They are generally 0.1 to 1 mm. The most efficient treatment of this kind of lesions is sclerotherapy. The goal of the study is to reveal complications of sclerotherapy applied in telangiectasia, and reticular vein and to determine prevention ways. Materials and Method: A total of 350 patients who were treated due to their varicose veins between February 2016 and January 2017 by sclerotherapy have been involved in the study. In all sclerotherapy procedures, %0.5 polidocanol was used, and 24-hour elastic bandage was applied to all patients after the procedure. All patients received 12 courses of sclerotherpy in one year. During each course, patients were administered 1 vial of 0.5% polidocanol. Result: Thrombophlebitis was developed in six patients, one of who developed the deep vein thrombosis. Anaphylactic reaction was developed in none of patients. Permenant pigmentatiton was observed in three patients. Conclusion: Sclerotherapy is one easily applicable treatment method for varicose veins which has low complication risk, and does not require hospitalization. It is primarily a cosmetic procedure, so it is quite important to know about its possible complications and how to handle them

Özet

Amaç: Alt ekstremite varisleri sık görülen, hayat kalitesinde ve iş gücünde ciddi kayıplara neden olan bir hastalıktır. Telenjiektaziler kapiller dolaşımın venöz kısmında oluşan mor renkli genişlemiş yapılardır. Genellikle 0.1-1 mm arasındadır. Bu tipteki lezyonlarda en etkin tedavi yöntemi skleroterapidir. Çalışmanın amacı da telenjiektazik ve retiküler venlerde uygulanan skleroterapilerin komplikasyonlarını belirtmek ve bunlardan kaçınmanın yollarını belirlemektir.Gereç ve Yöntem: Şubat 2016-Ocak 2017 arasında variköz venleri nedeniyle skleroterapi uygulanan toplam 350 hasta çalışmaya dahil edildi. Skleroterapi işlemlerinin tamamında %0.5 polidokanol kullanıldı. Hastaların tamamına işlem sonrası 24 saat elastik bandaj uygulaması yapıldı. Hastaların tamamına ayda bir kere olmak üzere bir yıl boyunca toplam 12 seans skleroterapi uygulanmıştır. Her seansda hastalara 1 ampul %0.5 polidokanol uygulanmıştır. Bulgular: Toplam 6 hastada tromboflebit gelişti. Bu hastaların bir tanesinde derin ven trombozu gelişti. Hastaların hiçbirinde anaflaktik reaksiyon görülmedi. Toplam 3 hastada kalıcı pigmentasyon artışı görüldü.Sonuç: Skleroterapi kolay uygulanabilen, komplikasyon riski az olan, hastaneye yatış gerektirmeyen, öncelikli kozmetik amaçlı yapılan varis tedavi yöntemlerinden bir tanesidir. Skleroterapi tedavisi çoğunlukla kozmetik amaçlı yapılmasından dolayı komplikasyonlarını bilmek ve o komplikasyonların tedavisine hakim olmak çok önemlidir.

🔖

Cite This Article

KAVALA, A. A., TÜRKYILMAZ, S. (2018). Sclerotherapy and complications in telangiectasia veins. Bakırköy Tıp Dergisi, Cilt: 14 - Sayı: 2, 222–241. https://ajindex.com/articles/132068

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Rabe E, Breu FX, Cavezzi A, Coleridge Smith P, Frullini A, Gillet JL, et al. European guidelines for sclerotherapy in chronic venous disorders. Phlebology 2014;29:338-54. [CrossRef] Wittens C, Davies AH, Bækgaard N, Broholm R, Cavezzi A, Chastanet S, de Wolf M, et al. Editor’s Choice - Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2015;49:678- 737. [CrossRef] Nicolaides AN, Allegra C, Bergan J, Bradbury A, Cairols M, Carpentier P, et al. Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. Int Angiol 2008;27:1-59
  2. Kabnick L, Sadeck M. Varicose veins: Endovenous ablation and sclerotherapy. In: Cronenwett JL, Johnston KW, editors. Rutherford’s Vascular Surgery. Philadelphia: Elsevier; 2014. p. 885-901.
  3. Rabe E, Pannier -Fisher F, Gerlach H, Breu Fx. German Society of Phlebology. Guidelines for Scleroterapy of varicose veins Dermatol Surg 2004;30:687-93.
  4. Khunger N, Sacchidanand S. Standard guidelines for care: sclerotherapy in dermatology. Indian J Dermatol Venereol Leprol 2011;77:222-31. [CrossRef] Guex JJ, Allaert FA, Gillet JL, Chleir F. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005;31:123-8. [CrossRef] Goldman MP, Sadick NS, Weiss RA. Cutaneous necrosis, telangiectatic matting and hyperpigmentation following sclerotherapy. Etiology, prevention, and treatment. Dermatol Surg 1995;21;19-29. [CrossRef] Rabe E, Pannier F. Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology. Dermatol Surg 2010;36:968-75. [CrossRef]